CRIS Current Research Information System

POLITO, LETIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.377
NA - Nord America 7.323
AS - Asia 7.122
AF - Africa 469
SA - Sud America 380
Continente sconosciuto - Info sul continente non disponibili 363
OC - Oceania 13
Totale 23.047
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.167
IT - Italia 3.370
SG - Singapore 1.954
VN - Vietnam 1.818
CN - Cina 1.694
GB - Regno Unito 920
HK - Hong Kong 579
DE - Germania 552
NL - Olanda 552
SE - Svezia 450
FR - Francia 325
IN - India 285
UA - Ucraina 256
BR - Brasile 253
RU - Federazione Russa 221
CI - Costa d'Avorio 193
IE - Irlanda 169
FI - Finlandia 155
KR - Corea 138
BD - Bangladesh 133
ZA - Sudafrica 124
JP - Giappone 109
CA - Canada 100
BG - Bulgaria 62
EE - Estonia 61
PH - Filippine 61
AR - Argentina 54
ID - Indonesia 51
BE - Belgio 47
ES - Italia 45
JO - Giordania 44
TH - Thailandia 41
AT - Austria 35
IQ - Iraq 35
TR - Turchia 34
TG - Togo 29
SC - Seychelles 28
GR - Grecia 27
IR - Iran 26
CH - Svizzera 25
PL - Polonia 25
NG - Nigeria 21
MX - Messico 20
EG - Egitto 19
TW - Taiwan 19
PK - Pakistan 18
CL - Cile 17
RO - Romania 17
MY - Malesia 15
SA - Arabia Saudita 15
EC - Ecuador 14
CO - Colombia 13
DZ - Algeria 12
PT - Portogallo 12
UZ - Uzbekistan 12
LT - Lituania 11
LY - Libia 11
JM - Giamaica 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
ET - Etiopia 9
VE - Venezuela 7
HR - Croazia 6
HU - Ungheria 6
PE - Perù 6
CZ - Repubblica Ceca 5
KZ - Kazakistan 5
MA - Marocco 5
TN - Tunisia 5
CR - Costa Rica 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
IL - Israele 4
UY - Uruguay 4
BW - Botswana 3
HN - Honduras 3
KE - Kenya 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
SI - Slovenia 3
SN - Senegal 3
AL - Albania 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
CY - Cipro 2
GH - Ghana 2
GP - Guadalupe 2
GU - Guam 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 22.663
Salva come PNG Salva come JPEG
Città #
Singapore 1.374
Southend 738
Ashburn 734
Hong Kong 551
Fairfield 543
Santa Clara 522
Chandler 494
Ho Chi Minh City 446
Bologna 437
Hanoi 378
San Jose 373
Hefei 270
Woodbridge 267
Houston 250
Beijing 245
Wilmington 243
Seattle 221
Ann Arbor 209
Princeton 206
Council Bluffs 204
Abidjan 193
Cambridge 193
Milan 191
Dong Ket 186
Boardman 178
Jacksonville 178
Dublin 169
Rome 157
Los Angeles 121
Helsinki 119
Turin 115
Seoul 110
Lauterbourg 105
Nanjing 93
Tokyo 91
Westminster 84
Padova 83
Berlin 75
Jinan 64
New York 64
Sofia 61
Buffalo 60
Catania 51
Da Nang 50
Frankfurt am Main 49
Haiphong 48
Dallas 47
Brussels 46
Saint Petersburg 45
Shenyang 45
Amman 44
Johannesburg 44
Shanghai 43
São Paulo 43
Guangzhou 42
Naples 41
Redondo Beach 40
Florence 37
Medford 37
Hebei 36
Mülheim 35
Nanchang 35
Redmond 35
San Diego 35
Falkenstein 33
London 33
Lappeenranta 32
Phoenix 32
Changsha 31
Des Moines 31
Jakarta 31
Redwood City 31
Zhengzhou 31
Foligno 29
Lomé 29
Modena 26
Toronto 26
Biên Hòa 25
Thái Nguyên 25
Verona 25
Bengaluru 24
Forlì 23
Chicago 22
Dearborn 22
Terni 22
Tianjin 22
Bangkok 21
Ferrara 21
Hangzhou 21
Orem 21
Abeokuta 20
Bari 20
Montreal 20
Genoa 19
Hyderabad 19
Can Tho 18
Ha Long 17
Bern 16
Chieti 16
Hải Dương 16
Totale 13.193
Salva come PNG Salva come JPEG
Nome #
Scienze e Ricerche 1.408
biomedicines (ISSN 2227-9059) 1.177
Frontiers in Pharmacology 424
Ricin: An ancient story for a timeless plant toxin 324
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma 282
Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1 250
Frontiers in Pharmacology Experimental Pharmacology and Drug Discovery 250
Survival and death of intestinal cells infected by Chlamydia trachomatis 238
Membrane lipidome reorganization correlates with the fate of neuroblastoma cells supplemented with fatty acids. 236
The 1.4.ANG. structure of dianthin 30 indicates a role of surface potential at the active site of type 1 ribosome inactivating proteins. 233
Distribution of RIP activity in tissue extracts from Fragaria x ananassa (strawberry) and its correlation with environmental stress 226
Ribosome-inactivating proteins in edible plants and purification and characterization of a new ribosome-inactivating protein from Cucurbita moschata. 220
Characterization of highly toxic type 2 ribosome-inactivating proteins from Adenia lanceolata and Adenia stenodactyla (Passifloraceae) 220
High in vitro anti-tumor efficacy of dimeric rituximab/saporin-S6 immunotoxin 218
Binding and intracellular routing of the plant-toxic lectins, lanceolin and stenodactylin 215
Structure/function studies on two type 1 ribosome inactivating proteins: Bouganin and lychnin. 213
RIP activity in basic protein fractions of tissue extracts from Fragaria x ananassa 212
Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering? 211
Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview 208
(ClO4)2: Metallodrug Nanocontainer Delivery and Membrane Lipidomics of a Neuroblastoma Cell Line Coupled with a Liposome Biomimetic Model Focusing on Fatty Acid Reactivity 208
Momordica charantia, a nutraceutical approach for inflammatory related diseases 202
Rituximab and other new anti-CD20 mAbs for non-Hodgkin’s lymphoma treatment. 201
Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells 201
Potential therapeutic application of the plant toxin saporin-S6. 197
Ribosome-inactivating proteins from plants: A historical overview 197
Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody. 196
Saporin-S6: a useful tool in cancer therapy. 193
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY 192
Immunotoxins and other conjugates: pre-clinical studies. 191
Cancer Cell & Microenvironment 191
Matricaria genus as a source of antimicrobial agents: From farm to pharmacy and food applications 191
Plants Producing Ribosome-Inactivating Proteins in Traditional Medicine 190
Kirkiin: A New Toxic Type 2 Ribosome-Inactivating Protein from the Caudex of Adenia kirkii 190
Structure/funcion studies on type 1 ribosome inactivating proteins. 189
Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase 189
The role of xanthine oxidoreductase and uric acid in metabolic syndrome 188
Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy 188
ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells. 187
New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents 186
Sequence determination of lychnin, a type 1 ribosome-inactivating protein from Lychnis chalcedonica seeds. 185
Hyperuricaemia, xanthine oxidoreductase and ribosome-inactivating proteins from plants: The contributions of fiorenzo stirpe to frontline research 185
The fundamental contribution of prof. Stirpe (and his research group) to the broadening of the scientific perspective on xanthine oxidoreductase 183
Crystallization and preliminary X-ray diffraction data analysis of stenodactylin, a highly toxic type 2 ribosome-inactivating protein from Adenia stenodactyla. 183
Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6 183
The 1.4 Å Structure of Dianthin 30 Indicates a Role of Surface Potential at the Active Site of Type 1 Ribosome Inactivating Proteins 182
CD38 as a target of IB4 mAb carrying saporin-S6: Design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia 182
Plant Toxins as Potential Alternatives to Botulinum Toxin for Eye-Movement Disorder Therapy 181
Expression of CTLA-4 in non-human primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies. 181
Heterophyllin: A New Adenia Toxic Lectin with Peculiar Biological Properties 180
Xanthine oxidoreductase: One enzyme for multiple physiological tasks 179
A new potent and selective anti-lymphocytes-immunotoxin for the treatment of GVHD and lymphocyte-derived neoplasms 177
Structural studies on RIPs elucidates the differences in their action on polynucleotides. 177
Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling 176
Anti-tumor activity of Epratuzumab/saporin-S6. 173
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction 172
Antibody conjugates for sarcoma therapy: How far along are we? 172
Xanthine Oxidoreductase in Drug Metabolism: Beyond A Role as a Detoxifying Enzyme 171
Insights into penicillin-induced Chlamydia trachomatis persistence 171
Xanthine oxidoreductase in cancer: more than a differentiation marker 170
Due nuove tossine per la chemoablazione sperimentale nello strabismo e nei disordini del movimento (blefarospasmo). 169
Bouganin, an attractive weapon for immunotoxins 169
Epratuzumab/Saporin-S6: an anti-CD22 immunotoxin for selective depletion of B-cells neoplasms 166
Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives 166
Endocitosi e traffico intracellulare della Saporina-S6 164
Programmed death induced by saporin as compared to ricin in lymphoma cells. 163
Cell interaction of the type 1 RIP Saporin 160
Protein synthesis inhibition activity by strawberry tissue protein extracts during plant life cycle and under biotic and abiotic stresses 157
Hexadecenoic Fatty Acid Positional Isomers and De Novo PUFA Synthesis in Colon Cancer Cells 157
Epratuzumab/saporin-S6: a new anti-CD22 immunotoxin with a potent antitumour activity. 153
Women’s Special Issue Series: Biomedicines 151
Primi studi sull'attività Rip in fragola. 151
Sequence, structure, and binding site analysis of kirkiin in comparison with ricin and other type 2 rips 151
Targeting CTLA-4 by its recombinant ligands CD80/CD86: Perspectives towards the development of a novel anti-tumor therapeutic approach. 151
The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20 expressing cells and produces a synergistic toxic effect with Fludarabine 150
Morte cellulare programmataindotta dalle RIP ricina e saporina in cellule linfomatose. 148
Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme. 147
mAbs targeting CD20 and other lymphocyte CD markers in lymphoma treatment. 145
Xanthine Oxidoreductase In Atherosclerosis Pathogenesis: Not Only Oxidative Stress. 142
Inducible antiviral activity and rapid production of the Ribosome-Inactivating Protein I from Phytolacca heterotepala in tobacco 141
Saporin induces multiple death pathways in lymphoma cells with different intensity, timing as compared to ricin. 140
Anti-Cancer Agents in Medicinal Chemistry 140
Toxin and Immunotoxin Based Therapeutic Approaches 140
Methods and application in experimental pharmacology and drug discovery: 2021 138
Intracellular fate of saporin-S6, a putative drug for anti-cancer therapy 138
Epratuzumab/saporina-S6: una immunotossina anti-CD22 per la deplezione delle cellule B linfomatose 138
EVALUATION OF PLANT RIBOSOME-INACTIVATING PROTEIN TOXICITY ON INTESTINAL CELLS 136
Distribuzione dell’attività lectinica e tossica in piante appartenenti al genere Adenia (Passifloraceae) 132
Chronic kidney disease: Which role for xanthine oxidoreductase activity and products? 130
The ATG-saporin-S6 immunotoxin causes a complete depletion of activated T cells. 129
Xanthine Oxidoreductase: A Double-Edged Sword in Neurological Diseases 128
Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases 128
hLL2/saporin: un’immunotossina anti-CD22 con potente attività antitumorale. 127
Xanthine oxidoreductase: A leading actor in cardiovascular disease drama 127
Occupational sensitization to ribosome-inactivating proteins in researchers 126
Comparative Efficacy of Ribosome-Inactivating Protein-Containing Immunotoxins in 2D and 3D Models of Sarcoma 124
Gender Influence on XOR Activities and Related Pathologies: A Narrative Review 123
Pro-aging effects of xanthine oxidoreductase products 117
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells 117
Primary Sequence and 3D Structure Prediction of the Plant Toxin Stenodactylin 116
Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy 115
Totale 20.005
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.827 0 93 140 132 161 122 45 145 95 100 433 361
2022/20232.381 257 224 124 255 170 180 87 134 496 108 238 108
2023/20241.171 68 134 84 107 85 143 121 120 67 100 65 77
2024/20254.565 221 452 409 382 834 323 398 258 134 279 137 738
2025/20267.598 785 766 610 497 823 440 754 237 1.331 684 322 349
2026/2027367 353 14 0 0 0 0 0 0 0 0 0 0
Totale 23.047